ED

Elizabeth Douville

Life sciences executive

Montreal, Quebec

Overview

Work Experience

I
IRICoR

  • President & CEO

    2023

A
AmorChem

  • Founder

    2011

    AmorChem is a leading early-stage venture capital investing in research innovation and creating next-gen biotech companies in life sciences. The fund has 95M$ under management for pre-seed, seed and Series A investments.

GC
Genome Canada

  • Chair

    2019

  • Board Member

    2016 - 2019

CT
Corbin Therapeutics Inc

  • Board Member

    2017

    Corbin Therapeutics develops USP15 inhibitors to treat and manage neuroinflamation.

SI
SemaThera Inc

  • Board Member

    2020

    SemaThera develops anti-SEMA3A biologics to treat diabetic macular edema.

  • Board Observer

    2018 - 2020

IP
Inversago Pharma

  • Board Observer

    2018 - 2022

    Inversago Pharma develops next gen CB1 inverse agonists to treat Prader-Willi Syndrome

B
BioCanRx

  • Board Member

    2015 - 2020

B
BIOQuebec

  • Board Member

    2013 - 2018

Education

Investments

Inversago Pharma

Series A

Total Funding: $110M

Semathera

Series Unknown

Total Funding: $3M

Alethia BioTherapeutics

Series A

Total Funding: $16M

Relevant Websites